Access to anti-retroviral drugs, female in Mexico
Mexico: Access to anti-retroviral drugs, female was 58.0% in 2024. ▲ Rising
Access to anti-retroviral drugs, female in Mexico, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
In 2024, access to anti-retroviral drugs, female in Mexico stood at 58.0%.
Compared with earlier readings it is up 5.5% on the previous year and up 34.9% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Mexico peaked at 62.0% in 2021 and was at its lowest, 9.0%, in 2000.
Mexico ranks 105th of 141 countries on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 25 years of available data.
Access to anti-retroviral drugs, female in Mexico, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 9.0% | — |
| 2001 | 11.0% | +22.2% |
| 2002 | 13.0% | +18.2% |
| 2003 | 17.0% | +30.8% |
| 2004 | 18.0% | +5.9% |
| 2005 | 20.0% | +11.1% |
| 2006 | 23.0% | +15.0% |
| 2007 | 25.0% | +8.7% |
| 2008 | 27.0% | +8.0% |
| 2009 | 29.0% | +7.4% |
| 2010 | 30.0% | +3.4% |
| 2011 | 31.0% | +3.3% |
| 2012 | 44.0% | +41.9% |
| 2013 | 43.0% | -2.3% |
| 2014 | 43.0% | +0.0% |
| 2015 | 48.0% | +11.6% |
| 2016 | 49.0% | +2.1% |
| 2017 | 50.0% | +2.0% |
| 2018 | 52.0% | +4.0% |
| 2019 | 56.0% | +7.7% |
| 2020 | 59.0% | +5.4% |
| 2021 | 62.0% | +5.1% |
| 2022 | 59.0% | -4.8% |
| 2023 | 55.0% | -6.8% |
| 2024 | 58.0% | +5.5% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 19.2% | 9.0% | 29.0% | 10 |
| 2010s | 44.6% | 30.0% | 56.0% | 10 |
| 2020s | 58.6% | 55.0% | 62.0% | 5 |
Countries ranked near Mexico
- 103 Kazakhstan 60.0% compare
- 103 Kyrgyzstan 60.0% compare
- 105 Bulgaria 58.0% compare
- 105 Kuwait 58.0% compare
- 108 Greece 57.0% compare
- 108 Timor-Leste 57.0% compare
More gender data for Mexico
- Child population (UN estimates and projections) 30,197 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -0.9402 % change on previous year (2030)
- Population 106,708 (2030)
- Working-age population (UN estimates and projections) 106,708 (2030)
- Population (UN estimates and projections), annual growth rate 1.16 % change on previous year (2030)
- Age population, age 00, female, interpolated 978,858 (2025)
- Age population, age 00, male, interpolated 1.01 million (2025)
- Age population, age 01, female, interpolated 984,557 (2025)
- Age population, age 01, male, interpolated 1.02 million (2025)
- Age population, age 02, female, interpolated 992,716 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Mexico?
- Access to anti-retroviral drugs, female in Mexico was 58.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Mexico?
- The highest recorded value was 62.0% in 2021.
- What is the lowest access to anti-retroviral drugs, female recorded in Mexico?
- The lowest recorded value was 9.0% in 2000.
- How does Mexico rank for access to anti-retroviral drugs, female?
- Mexico ranks 105th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Mexico?
- Over the last ten years it is up 34.9%. The long-run trend across the full record is rising.
- Where does this Mexico data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.